[BENGALURU] The European Medicines Agency (EMA) has recommended approval for Lynparza in patients with a form of prostate cancer and as a first-line maintenance treatment for a form of advanced...

SINCE joining Singapore Exchange (SGX)-listed specialty pharmaceutical company iX Biopharma, Janakan Krishnarajah has been getting involved in many new aspects of the drug making business.

[TOKYO] Takeda Pharmaceutical said on Wednesday it would sell its TachoSil surgical patch product to Corza Health for 350 million euros (S$563.7 million) as the Japanese company continues to...

[NEW YORK] Eastman Kodak, seeking to address the firestorm of allegations surrounding a Trump administration loan, said it mishandled the process of awarding stock option grants to its chief...

COVID-19 has been the rudest wake-up call to the importance of biomedical research. One in 200 diseases known to science have meaningful treatments, while drug candidates face a 10,000-to-one odds...

[NEW JERSEY]  Merck plans to take an equity stake and pay as much as US$4.5 billion in a series of deals with Seattle Genetics for two of its cancer drugs.

[BENGALURU] Gilead Sciences will acquire biopharmaceutical company Immunomedics for US$21 billion, a move that will strengthen its cancer portfolio by gaining access to a promising drug, the two...

[BENGALURU] Johnson & Johnson said on Thursday its experimental coronavirus vaccine prevented hamsters from getting severely ill, as the drugmaker seeks to begin large, late-stage studies in...

[WASHINGTON] Mylan received a warning from US regulators for failing to ensure key drug ingredients made at one of its plants in India were not contaminated.

[ZURICH] Nestle SA agreed to buy Aimmune Therapeutics Inc in a US$2.6 billion deal, adding a leader in the prevention of peanut allergies as demand for mainstream consumer goods slows.